ClinicalTrials.Veeva
Menu

Find clinical trials for Diabetes in Austin, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Type 2 Diabetes Mellitus
Diabetes Mellitus
Obesity
Type 1 Diabetes Mellitus
Diabetic Foot
Overweight
Foot Ulcer

Diabetes trials near Austin, TX, USA:

Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes (ReCET)

This study is designed to evaluate the safety and effectiveness of endoscopic intestinal re-cellularization therapy in individuals with type 2 diabetes...

Enrolling
Diabetes
Type2diabetes
Device: ReCET Treatment
Device: Sham Procedure
Endogenex

Austin, Texas, United States and 44 other locations

the efficacy and safety of icovamenib in participants with Type 2 Diabetes who are not achieving glycemic targets despite antihyperglycemic ...

Enrolling
Type 2 Diabetes
Drug: icovamenib 100mg
Drug: Placebo

Phase 2

Biomea Fusion

Austin, Texas, United States and 15 other locations

blood sugar that sometimes happens when injecting insulin in Type 1 diabetes patients. Participants will use continuous glucose monitoring t...

Active, not recruiting
Diabetes Mellitus, Type 1
Drug: Lispro
Drug: HDV-Lispro

Phase 2

Diasome Pharmaceuticals

Austin, Texas, United States of America and 27 other locations

of MODI, an insulin titration algorithm, in adults with type 1 diabetes (T1D) who use multiple daily insulin injections (MDI), or with type ...

Enrolling
Type 2 Diabetes (T2D)
Type 1 Diabetes (T1D)
Device: MODI Algorithm
DreaMed Diabetes

Austin, Texas, United States of America and 2 other locations

This is a phase 2 randomized, double-blind, placebo-controlled trial assessing the efficacy and safety of icovamenib in participants with Type 2 Diabetes...

Enrolling
Type 2 Diabetes
Drug: icovamenib 100 mg
Drug: Placebo

Phase 2

Biomea Fusion

Austin, Texas, United States and 15 other locations

Status recently updated

of the fully closed loop Omnipod M System in adults with type 2 diabetes using basal/bolus insulin therapy or basal-only insulin therapy, wi...

Not yet enrolling
Enrolling
Type 2 Diabetes Mellitus
Device: Device: Omnipod M System with study CGM
Device: Standard Therapy plus study CGM
Insulet

Austin, Texas, United States and 14 other locations

The purpose of this study is to assess the safety and tolerability of aleniglipron at doses up to 240 mg once daily (QD) in participants with T2DM wh...

Active, not recruiting
Obesity Type 2 Diabetes Mellitus
Weight Loss
Drug: Placebo
Drug: Aleniglipron

Phase 2

Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics

Austin, Texas, United States and 15 other locations

OPL-0401-201 is a multicenter study to investigate the safety and efficacy of OPL-0401 in patients with diabetes mellitus (DM) with diabetic...

Active, not recruiting
Non-proliferative Diabetic Retinopathy
Proliferative Diabetic Retinopathy
Drug: Placebo
Drug: OPL-0401 Dose 1

Phase 2

Valo Health

Austin, Texas, United States and 24 other locations

Locations recently updated

Diabetic Retinopathy (DR) is a common eye condition caused by diabetes, where high blood sugar levels damage the blood vessels in t...

Enrolling
Diabetic Retinopathy
Drug: Topical Steroid
Drug: Artificial Tears

Phase 2, Phase 3

AbbVie
AbbVie

Austin, Texas, United States of America and 2 other locations

This study is a Phase 1b/2a First-in-Human (FIH) clinical trial to assess the safety, tolerability, pharmacodynamics (PD), and efficacy of multiple a...

Enrolling
Type 1 Diabetes Patients
Type 1 Diabetes Mellitus
Drug: CNP-103
Drug: Placebo

Phase 1, Phase 2

COUR Pharmaceuticals

Austin, Texas, United States of America and 31 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems